Fifth Third Bancorp
AST.WS

Fifth Third Bancorp’s Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) AST.WS Stock Holding History

Fifth Third Bancorp’s Portfolio AST.WS Stock Details AST.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-165
Closed – – 2385
2017
Q2 		$0 Hold
165
– – ﹤0.01% 2353
2017
Q1 		$0 Hold
165
– – ﹤0.01% 2316
2016
Q4 		$0 Hold
165
– – ﹤0.01% 2399
2016
Q3 		$0 Hold
165
– – ﹤0.01% 2420
2016
Q2 		$0 Buy
+165
New +$86 ﹤0.01% 2465

Fifth Third Bancorp's AST.WS Position: Q3 2017 in Review

Fifth Third Bancorp sold out of Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) (AST.WS) in Q3 2017, closing a stake of 165 shares.

Fifth Third Bancorp first reported a position in AST.WS in Q2 2016 and held it in 5 quarters. The position peaked at $0 in Q2 2017. 3 funds tracked by Wall St. Rank hold AST.WS as of Q3 2017.

  • Fifth Third Bancorp reported no remaining Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position as of Q3 2017 after selling out during the quarter.
  • Fifth Third Bancorp sold 165 Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) shares in Q3 2017.
  • Fifth Third Bancorp first reported a position in Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) in Q2 2016 and held it in 5 quarters.
  • Fifth Third Bancorp's Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position peaked at $0 in Q2 2017.
  • 3 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) as of Q3 2017.

Based on Fifth Third Bancorp's 13F filing for Q3 2017, filed 14 Nov 2017.